⌘K

Login Start Free

Home/Filings/4/0001209191-22-014248

4//SEC Filing

Drygin Denis 4

Accession 0001209191-22-014248

CIK 0001505512other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 5:58 PM ET

Size

4.5 KB

Accession

0001209191-22-014248

Insider Transaction Report

Form 4

Period: 2022-03-01

Regulus Therapeutics Inc.RGLS

Chief Scientific Officer

Transactions

Purchase
Common Stock
2022-03-01$0.23/sh+76,686$17,638→ 100,000 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Regulus Therapeutics Inc.

CIK 0001505512

Entity typeother

Related Parties

1

filerCIK 0001819692

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 5:58 PM ET
Size: 4.5 KB

View on SEC.gov